Search results for " market"
Article
Good Manufacturing Practices: Challenges with Compliance
Muzzin (Emergent): One industry challenge is the need to continuously strike a balance between providing continual supply of products to the market with the approved facility and/or equipment while al…
Article
Cytiva Upgrades Massachusetts Contract Biomanufacturing Site with Increased Capacity and Automation Technologies
Biotechnology companies looking for assistance in bringing therapeutics to market faster can leverage the extensive technical support and single-use biomanufacturing expertise available at this enhanc…
Article
Step Up to GMP Manufacturing or Outsource to a CDMO: Considerations and Tips
Whether you are developing a new monoclonal antibody (mAb), cell therapy, gene therapy, or large-molecule biologic drug, the decision to tackle GMP manufacturing in-house or work with a contract devel…
Article
Flavivirus Vaccine: Accelerate Development and Production with Modern Tools and Solutions
In addition, vaccine production can be both costly and difficult to scale to meet market demands. This article gives an overview of modern tools and solutions, adding flexibility and speed to both ups…
Article
Biomanufacturing: Demand for Continuous Bioprocessing Increasing
Multi-column, countercurrent, and other variations of continuous chromatography units are just starting to enter the market. The classic and still predominant approach to bioprocessing, both upstream …
Article
Gene Therapies Push Viral Vector Production
“The CDMO market is currently fragmented with more new players offering to manufacture vectors. However, the capacity is still not covering the current needs. Capacity increases should resolve the sup…
Article
Is Not Using a CDMO Slowing Down Your Process Development?
Consider what process development capabilities you have versus what you could possibly gain from working with a CDMO to not only be successful, but also to improve your chances of getting to market …
Article
Approaches to Improve Efficiency in Biopharmaceutical Process Development
Click here to read the article >>
Time to experiment, time to clinic, and time to market are becoming even more important for developers and manufacturers of biopharmaceuticals. This a…
Article
Improving Capacity in DNA Plasmid Purification
Join Tony Hitchcock on May 6, 2020 to learn more about this critical market and how Cobra Biologics is working with Cytiva to develop a modern chromatography resin to help meet the demand.
Reg…
Article
The Future of Biopharma
When it comes to meeting unmet needs, biosimilars have a huge role to play, as they introduce competition to the market that can help to bring down the cost of expensive biopharmaceuticals. In the sec…